Acute Myeloid Leukemia; State University of New York Reports Research in Acute Myeloid Leukemia
Acute Myeloid Leukemia; State University of New York Reports Research in Acute Myeloid Leukemia
About this item
Full title
Acute Myeloid Leukemia; State University of New York Reports Research in Acute Myeloid Leukemia
Publisher
Atlanta: NewsRx
Journal title
Obesity, Fitness & Wellness Week, 2011, p.2061
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
A phase 1 clinical trial to evaluate the biologically effective dose and/or the maximally tolerated dose (MTD) of ATO in vivo in conjunction with high-dose cytarabine (Hidac) and idarubicin (Ida) in patients with AML aged < 60 years was conducted. Data were compared with 117 historic AML patients who had received treatment with Hidac/Ida. In total,...
Alternative Titles
Full title
Acute Myeloid Leukemia; State University of New York Reports Research in Acute Myeloid Leukemia
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_904134020
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_904134020
Other Identifiers
ISSN
1531-6386
E-ISSN
1532-4664
How to access this item
Log in as a Library member
